{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:24758425",
      "entity_text" : "aldosterone",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uniprot:P01019",
      "entity_text" : "angiotensin II",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "uaz:UAZ03045",
      "entity_text" : "AT 1  receptor",
      "entity_type" : "protein"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "Valsartan is a specific blocker of the binding of angiotensin II to the AT 1 receptor, blocking the vasoconstrictor effect and the adrenal aldosterone secretion induced by this peptide.",
  "reading_complete" : "2020-08-05T22:23:22Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:21:30Z",
  "trigger" : "blocking",
  "evidence" : [ "angiotensin II to the AT 1  receptor, blocking the vasoconstrictor effect and the adrenal aldosterone" ],
  "pmc_id" : "2899780",
  "score" : 0
}